InvestorsObserver is giving Inovio Pharmaceuticals Inc (INO) an Analyst Rating Rank of 16, meaning INO is ranked higher by analysts than 16% of stocks. The average price target for INO is $11 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating INO a Buy today. Find out what this means to you and get the rest of the rankings on INO!